Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 97469
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention seeks market forecast analyses for West Nile virus vaccine and anti-WNV monoclonal antibody for prophylaxis via Request for Quotation 75D301-26-Q-79208, with quotations due September 2, 2026 at 10:00 AM EST. This is a commercial acquisition under FAR Parts 12 and 13, resulting in award of a Time-and-Materials purchase order with no set-aside applied.
Place of performance is Atlanta, Georgia. The contractor shall conduct two comprehensive market forecast analyses encompassing market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications per the Statement of Work. The CDC will provide Target Product Profiles as project inputs. Epidemiological datasets from ArboNET are available upon request from CDC in addition to publicly available data. Baseline development and investment costs must be independently sourced through stakeholder interviews and external estimation. Structured interviews with up to 20 subject matter experts, industry leaders, and federal agency stakeholders are preferred for external stakeholder engagement, though quantitative survey methodologies are acceptable. Peer-reviewed manuscripts should be submitted for publication in month 12 to high-impact journals such as JAMA, Lancet Infectious Disease, or Vaccine, with CDC engaging in shared decision-making on journal selection.
The period of performance runs September 30, 2026 through September 29, 2027 (12 months). Monthly invoicing is required. The NAICS code is 541715, Research and Development in Physical Engineering and Life Sciences; the PSC code is AN11, Health R&D Services, Epidemiology. A Q&A document has been added to the solicitation file.
Notice text
3 versions
Update #3 · Latest ·
Q&A document added.
Due Date for all quotes has been updated to September 2, 2026 at 10am est.
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order.
Description of Requirement
The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses:
- Human West Nile virus (WNV) vaccine
- Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis
The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW).
Product or Service Code: AN11 – Health R&D Services, Epidemiology
NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences
Period of Performance: September 30, 2026 – September 29, 2027 (12 months).
Delivery
Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required.
Submission Requirements
Offerors shall submit the following:
- Completed pricing for all CLINs.
- A Time-and-Materials quotation for the entire period of performance.
- Written acknowledgement of the Statement of Work confirming the ability to perform the required services.
- Active System for Award Management (SAM) registration, including UEI, with no active exclusions.
- Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.
Update #2 ·
Due Date for all quotes has been updated to September 2, 2026 at 10am est.
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order.
Description of Requirement
The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses:
- Human West Nile virus (WNV) vaccine
- Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis
The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW).
Product or Service Code: AN11 – Health R&D Services, Epidemiology
NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences
Period of Performance: September 30, 2026 – September 29, 2027 (12 months).
Delivery
Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required.
Submission Requirements
Offerors shall submit the following:
- Completed pricing for all CLINs.
- A Time-and-Materials quotation for the entire period of performance.
- Written acknowledgement of the Statement of Work confirming the ability to perform the required services.
- Active System for Award Management (SAM) registration, including UEI, with no active exclusions.
- Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.
Update #1 ·
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format prescribed in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
The Centers for Disease Control and Prevention (CDC) is issuing Request for Quotation (RFQ) No. 75D301-26-Q-79208 using the procedures of FAR Part 12, Acquisition of Commercial Products and Commercial Services, in conjunction with FAR Part 13, Simplified Acquisition Procedures, for the acquisition of Market Forecast Analyses for West Nile Virus (WNV) Vaccine and Anti-WNV Monoclonal Antibody for Prophylaxis. The acquisition will result in the award of a Time-and-Materials (T&M) purchase order.
Description of Requirement
The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), requires contractor support to conduct two comprehensive market forecast analyses:
- Human West Nile virus (WNV) vaccine
- Anti-WNV monoclonal antibody (mAb) for seasonal pre-exposure prophylaxis
The contractor shall perform market forecasting, epidemiologic analyses, health economic modeling, stakeholder engagement, commercial assessments, financial analyses, and preparation of peer-reviewed publications in accordance with the attached Statement of Work (SOW).
Product or Service Code: AN11 – Health R&D Services, Epidemiology
NAICS Code: 541715- Research and Development in the Physical Engineering, and Life Sciences
Period of Performance: September 30, 2026 – September 29, 2027 (12 months).
Delivery
Services shall be performed in accordance with the attached Statement of Work. Deliverables shall be submitted in accordance with the deliverable schedule identified in Section 7 of the Statement of Work. Monthly invoicing is required.
Submission Requirements
Offerors shall submit the following:
- Completed pricing for all CLINs.
- A Time-and-Materials quotation for the entire period of performance.
- Written acknowledgement of the Statement of Work confirming the ability to perform the required services.
- Active System for Award Management (SAM) registration, including UEI, with no active exclusions.
- Any required Artificial Intelligence (AI) disclosures and AI Compliance and Risk Management Plan, if applicable.
Files
| File | Type | Posted |
|---|---|---|
| QandA_in red.docx | DOCX document | |
| A19 75D301-26-Q-79208.doc | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Market forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis | Award Notice | |
| This notice | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines | CDC Office of Acquisition Services | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity